The use of photodynamic therapy in dermatology

Giornale Italiano di Dermatologia e Venereologia

Volumn 145, Issue 5, 2010, Pages 613-630

  Babilas, P ^a   Szeimies, R M ^b  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Klinikum Vest Academic Teaching Hospital   (Germany)

Author keywords

Aminolevulinic acid; Methyl aminolevulinate; Photochemotherapy; Skin diseases

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; COSMETIC; DITHRANOL; HEMATOPORPHYRIN; PHOTOSENSITIZING AGENT; PORPHYRIN;

ACNE VULGARIS; ACTINIC KERATOSIS; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CARBON DIOXIDE MEASUREMENT; CONDYLOMA ACUMINATUM; CRYOSURGERY; GRANULOMA ANNULARE; HUMAN; HYPERPLASIA; IMMUNOMODULATION; LIGHT; PHOTOAGING; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PSORIASIS VULGARIS; SCLERODERMA; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; VERRUCA VULGARIS;

EID: 78650753477     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Szeimies Rm, Dräger J, Abels C, Landthaler M. History of photodynamic therapy in dermatology. Photodynamic therapy and fluorescence diagnosis in dermatology. Amsterdam: Elsevier; 2001. p. 3-16.
2. Von Tappeiner H. Über die Wirkung Fluorescierender Stoffe auf Infusorien: nach Versuchen von O. Raab. Mmw 1900;47:5-7.
3. Dougherty TJ, Grindey GB, Fiel R, Weishaupt KR, Boyle DG. Photoradiation Therapy. Ii. Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 1975;55:115-21.
4. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978;38:2628-35. (Pubitemid 8390848)
5. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 2004;30:264-71.
6. Braathen LR. [Photodynamic Therapy]. Tidsskr nor Laegeforen 2001;121:2635-6.
7. Dragieva G, Hafner J, Dummer R, Schmid-Grendelmeier P, Roos M, Prinz BM et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004;77:115-21. (Pubitemid 38116882)
8. Dragieva G, Prinz BM, Hafner J, Dummer R, Burg G, Binswanger U et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004; 151:196-200. (Pubitemid 39061299)
9. Morton CA. Photodynamic therapy for nonmelanoma skin cancer and more? Arch Dermatol 2004; 140:116-20.
10. Schweitzer VG. Photofrin-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med 2001;29:305-13.
11. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin Ix: basic principles and present clinical experience. J Photochem Photobiol B 1990;6:143-8.
12. Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current Review And Update. Mol Immunol 2003;39:1133-6.
13. Szeimies RM, Karrer S, Abels C, Landthaler M, Elmets C. Photodynamic therapy in dermatology. Dermatological phototherapy and photodiagnostic methods. Berlin: Springer; 2001. p. 209-47.
14. Juzeniene A, Juzenas P, Iani V, Moan J. Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem Photobiol 2002;76:329-34.
15. Christiansen K, Bjerring P, Troilius A. 5-Ala for photodynamic photorejuvenation - Optimization of treatment regime based on normalskin fluorescence measurements. Lasers Surg Med 2007;39:302-10. (Pubitemid 46717529)
16. Hauschild A, Stockfleth E, Popp G, Borrosch F, Bruning H, Dominicus R et al. Optimization of photodynamic therapy with a novel selfadhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase Iii studies. Br J Dermatol 2009;160:1066-74.
17. Baas P, Saarnak AE, Oppelaar H, Neering H, Stewart FA. Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: A Phase I/Ii Study. Br J Dermatol 2001;145:75-8. (Pubitemid 32862789)
18. Lui H, Hobbs L, Tope WD, Lee PK, Elmets C, Provost N et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. Arch Dermatol 2004;140:26-32.
19. Brown SB. The role of light in the treatment of non-melanoma skin cancer using methyl aminolevulinate. J Dermatolog Treat 2003;14(Suppl3):11-4.
20. Szeimies RM, Abels C, Fritsch C, Karrer S, Steinbach P, Bäumler W et al. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. J Invest Dermatol 1995;105:672-7.
21. Piacquadio DJ, Chen DM, Farber HF, Fowler JF Jr, Glazer SD, Goodman JJ et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol 2004;140:41-6.
22. Morton CA, Brown SB, Collins S, Ibbotson S, Jenkinson H, Kurwa H et al. Guidelines for topical photodynamic therapy: report of a workshop of the british photodermatology group. Br J Dermatol 2002;146:552-67.
23. Morton CA, Whitehurst C, Moore JV, Mackie RM. Comparison of red and green light in the treatment of bowen's disease by photodynamic therapy. Br J Dermatol 2000;143:767-72.
24. Haller JC, Cairnduff F, Slack G, Schofield J, Whitehurst C, Tunstall R et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000; 143:1270-5.
25. Soler AM, Warloe T, Berner A, Giercksky KE. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001;145:467-71.
26. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000;142:338-9.
27. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 2002;17:173-86.
28. Juzeniene A, Juzenas P, Ma LW, lani V, Moan J. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci 2004; 19:139-49.
29. Karrer S, Bäumler W, Abels C, Hohenleutner U, Landthaler M, Szeimies RM. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med 1999;25:51-9. (Pubitemid 29379091)
30. Szeimies RM, Hein R, Bäumler W, Heine A, Landthaler M. A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol 1994;74:117-9. (Pubitemid 24102471)
31. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 2003; 139:1313-20.
32. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Carter LN. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J Drugs Dermatol 2004;3:S15-19.
33. Melnick S. Cystic acne improved by photodynamic therapy with short-contact 5-aminolevulinic acid and sequential combination of intense pulsed light and blue light activation. J Drugs Dermatol 2005;4:742-5.
34. Santos MA, Belo VG, Santos G. Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: comparative study. Dermatol Surg 2005;31:910-5.
35. Avram DK, Goldman MP. Effectiveness and safety of Ala-Ipl in treating actinic keratoses and photodamage. J Drugs Dermatol 2004;3:S36-9.
36. Kim HS, Yoo JY, Cho KH, Kwon OS, Moon SE. Topical photodynamic therapy using intense pulsed light for treatment of actinic keratosis: clinical and histopathologic evaluation. Dermatol Surg 2005;31:33-6; Discussion 36-7.
37. Alster TS, Tanzi EL, Welsh EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol 2005;4:35-8.
38. Dover JS, Bhatia AC, Stewart B, Arndt KA. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 2005;141:1247-52.
39. Goldman MP, Weiss RA, Weiss MA. Intense pulsed light as a nonablative approach to photoaging. Dermatol Surg 2005;31:1179-87; Discussion 1187.
40. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Lewis TL. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J Drugs Dermatol 2004;3:S6-9.
41. Babilas P, Kohl E, Maisch T, Böcker H, Gross B, Branzan AL et al. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy. Br J Dermatol 2006;154:712-8.
42. Babilas P, Knobler R, Hummel S, Gottschaller C, Maisch T, Koller M et al. Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. Br J Dermatol 2007; 157; 111-7. (Pubitemid 46934274)
43. Babilas P, Travnik R, Werner A, Landthaler M, Szeimies RM. Splitface-study using two different light sources for topical PDT of actinic keratoses: non-inferiority of the led system. J Dtsch Dermatol Ges 2008;6:25-32.
44. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003;19:134-41. (Pubitemid 36889801)
45. Varma S, Wilson H, Kurwa HA, Gambles B, Charman C, Pearse AD et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001;144:567-74. (Pubitemid 32232013)
46. Yang CH, Lee JC, Chen CH, Hui CY, Hong HS, Kuo HW. Photodynamic therapy for bowenoid papulosis using a novel incoherent light-emitting diode device. Br J Dermatol 2003;149:1297-9.
47. Morton CA. Methyl aminolevulinate (Metvix) photodynamic therapy - Practical pearls. J Dermatolog Treat 2003;14(Suppl 3):23-6.
48. Wolf P, Fink-Puches R, Reimann-Weber A, Kerl H. Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site. Dermatology 1997;194:53-4. (Pubitemid 27047333)
49. Schreml S, Gantner S, Steinbauer J, Babilas P, Landthaler M, Szeimies RM. Melanoma promotion after photodynamic therapy of a suspected bowen's disease lesion. Dermatology 2009;219:279-81.
50. Bissonnette R, Bergeron A, Liu Y. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol 2004;3:S26-31.
51. Stender IM, Bech-Thomsen N, Poulsen T, Wulf HC. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 1997;66:493-6. (Pubitemid 127470195)
52. Moore JV, Allan E. Pulsed ultrasound measurements of depth and regression of basal cell carcinomas after photodynamic therapy: relationship to probability of 1-year local control. Br J Dermatol 2003;149:1035-40. (Pubitemid 37541991)
53. Foley P. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatolog Treat 2003; 14(Suppl 3): 15-22.
54. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, CalzavaraPinton PG, Zane C et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002;47:258-62.
55. Tourna D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004;140:33-40. (Pubitemid 38090268)
56. Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and bowen's disease: an effective addition to treatment: a pilot study. Dermatol Surg 2004;30:63-6. (Pubitemid 38174032)
57. Holmes MV, Dawe RS, Ferguson J, Ibbotson SH. A randomized, double-blind, placebo-controlled study of the efficacy of tetracaine gel (Ametop) for pain relief during topical photodynamic therapy. Br J Dermatol 2004;150:337-40. (Pubitemid 38352473)
58. Moloney FJ, Collins P. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Br J Dermatol 2007;157:87-91. (Pubitemid 46934264)
59. Rodriguez L, Batlle A, Di Venosa G, Battah S, Dobbin P, Macrobert AJ et al. Mechanisms of 5-aminolevulinic acid ester uptake in mammalian cells. Br J Pharmacol 2006;147:825-33.
60. Steinbauer JM, Schreml S, Babilas P, Zeman F, Karrer S, Landthaler M et al. Topical Photodynamic therapy with porphyrin precursors-assessment of treatment-associated pain in a retrospective study. Photochem Photobiol Sci 2009;8:1111-6.
61. Sandberg C, Stenquist B, Rosdahl I, Ros Am, Synnerstad I, Karlsson M et al. Important factors for pain during photodynamic therapy for actinic keratosis. Acta Derm Venereol 2006;86:404-8.
62. Lehmann P. [Side effects of topical photodynamic therapy]. Hautarzt 2007;58:597-603.
63. Wulf HC, Philipsen P. Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not to 5-aminolaevulinic acid after photodynamic therapy. Br J Dermatol 2004;150:143-5.
64. Guillen C, Sanmartin O, Escudero A, Botella-Estrada R, Sevila A, Castejon P. Photodynamic therapy for in situ squamous cell carcinoma on chronic radiation dermatitis after photosensitization with 5-aminolaevulinic acid. J Eur Acad Dermatol Venereol 2000; 14:298-300.
65. Babilas P, Landthaler M, Szeimies RM. [Actinic Keratoses]. Hautarzt 2003;54:551-60; Quiz 561-552.
66. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society For Photodynamic Therapy In Dermatology, 2005. J Am Acad Dermatol 2007;56:125-43.
67. Morton CA, Mckenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008;159:1245-66.
68. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003;14:99-106.
69. Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003;48:227-32.
70. Morton C, Campbell S, Gupta G, Keohane S, Lear J, Zaki I et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate- photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006;155:1029-36.
71. Morton CA, Whitehurst C, Mccoll JH, Moore JV, Mackie RM. Photodynamic therapy for large or multiple patches of bowen disease and basal cell carcinoma. Arch Dermatol 2001 ; 137:319-24.
72. Horn M, Wolf P, Wulf HC, Warloe T, Fritsch C, Rhodes Le et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003;149:1242-9.
73. Rhodes LE, De Rie M, Enstrom Y, Groves R, Morken T, Goulden V et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004;140:17-23.
74. Wang I, Bendsoe N, Klinteberg CA, Enejder AM, Andersson-Engels S, Svanberg S et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase Iii clinical trial. Br J Dermatol 2001;144:832-40.
75. Basset-Seguin N, Ibbotson SH, Emtestam L, Tarstedt M, Morton C, Maroti M et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008;18:547-53.
76. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007;156:793-801.
77. Kuijpers DI, Smeets NW, Krekels GA, Thissen MR. Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with mohs micrographic surgery. Dermatol Surg 2004;30:794-8.
78. Szeimies RM, Ibbotson S, Murrell DF, Rubel D, Frambach Y, De Berker D et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008; 22:1302-11.
79. Salim A, Leman JA, Mccoll JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in bowen's disease. Br J Dermatol 2003;148:539-43. (Pubitemid 36461334)
80. Morton C, Horn M, Leman J, Tack B, Bedane C, Tjioe M et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006;142:729-35.
81. Hayami J, Okamoto H, Sugihara A, Horio T. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J Dermatol 2007;34:320-7.
82. Karrer S, Bosserhoff Ak, Weiderer P, Landthaler M, Szeimies RM. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Br J Dermatol 2004;151:776-83.
83. Karrer S, Szeimies RM. [Photodynamic therapy: non-oncologic indications.]. Hautarzt 2007;58:585-96.
84. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002;146:178-88.
85. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001;144:575-9.
86. Karrer S, Abels C, Landthaler M, Szeimies RM. Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol 2000;80:26-7.
87. Stender IM, Na R, Fogh H, Gluud C, Wulf HC. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 2000;355:963-6.
88. Brentjens MH, Yeung-Yue KA, Lee PC, Tyring SK. Human papillomavirus: a review. Dermatol Clin 2002;20:315-31.
89. Fehr MK, Chapman CF, Krasieva T, Tromberg BJ, Mccullough JL, Berns MW et al. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. Am J Obstet Gynecol 1996;174:951-7.
90. Ross EV, Romero R, Kollias N, Crum C, Anderson RR. Selectivity of protoporphyrin ix fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Br J Dermatol 1997;137:736-42.
91. Smetana Z, Malik Z, Orenstein A, Mendelson E, Ben-Hur E. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med 1997;21:351-8.
92. Ammann R, Hunziker T, Braathen LR. Topical photodynamic therapy in Verrucae. A pilot study. Dermatology 1995;191:346-7.
93. Stender IM, Lock-Andersen J, Wulf HC. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study. Clin Exp Dermatol 1999;24:154-9.
94. Fabbrocini G, Di Costanzo MP, Riccardo AM, Quarto M, Colasanti A, Roberti G et al. Photodynamic therapy with topical delta-aminolaevulinic acid for the treatment of plantar warts. J Photochem Photobiol B 2001;61:30-4.
95. Frank RG, Bos JD. Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. Genitourin Med 1996;72:70-1.
96. Szeimies RM, Schleyer V, Moll I, Stocker M, Landthaler M, Karrer S. Adjuvant photodynamic therapy does not prevent recurrence of condylomata acuminata after carbon dioxide laser ablation-a phase iii, prospective, randomized, bicentric, double-blind study. Dermatol Surg 2009;35:757-64.
97. Bissonnette R, Zeng H, Mclean DI, Korbelik M, Lui H. Oral aminolevulinic acid induces protoporphyrin Ix fluorescence in psoriatic plaques and peripheral blood cells. Photochem Photobiol 2001;74:339-45.
98. Stringer MR, Collins P, Robinson DJ, Stables GI, Sheehan-Dare RA. The accumulation of protoporphyrin Ix in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol 1996; 107:76-81.
99. Boehncke WH, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 1994;343:801.
100. Collins P, Robinson DJ, Stringer MR, Stables GI, Sheehan-Dare RA. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997;137:743-9.
101. Robinson DJ, Collins P, Stringer MR, Vernon DI, Stables GI, Brown SB et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 1999;79:451-5.
102. Beattie PE, Dawe RS, Ferguson J, Ibbotson SH. Lack of efficacy and tolerability of topical pdt for psoriasis in comparison with narrowband uvb phototherapy. Clin Exp Dermatol 2004;29:560-2.
103. Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, Szeimies RM, Zwingers T, Honigsmann H et al. Topical aminolevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol 2005;152:279-83.
104. Schleyer V, Radakovic-Fijan S, Karrer S, Zwingers T, Tanew A, Landthaler M et al. Disappointing results and low tolerability of photodynamic therapy with topical 5-aminolaevulinic acid in psoriasis. A randomized, double-blind phase I/Ii study. J Eur Acad Dermatol Venereol 2006;20:823-8.
105. Stender IM, Wulf HC. Kobner reaction induced by photodynamic therapy using delta-aminolevulinic acid. A case report. Acta Derm Venereol 1996;76:392-3.
106. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ala-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115:183-92.
107. Pollock B, Turner D, Stringer MR, Bojar RA, Goulden V, Stables GI et al. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol 2004;151:616-22.
108. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J Dermatol 2006;154:969-76.
109. Hörfelt C, Funk J, Frohm-Nilsson M, Wiegleb Edstrom D, Wennberg AM. Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study. Br J Dermatol 2006;155:608-13.
110. Seyger MM, Van Den Hoogen FH, De Boo T, De Jong EM. Reliability of two methods to assess morphea: skin scoring and the use of a durometer. J Am Acad Dermatol 1997;37:793-6.
111. Rook AH, Freundlich B, Jegasothy BV, Perez MI, Barr WG, Jimenez SA et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol 1992;128:337-46.
112. Hillemanns P, Untch M, Prove F, Baumgartner R, Hillemanns M, Korell M. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999;93:71-4.
113. Uebelhoer NS, Dover JS. Photodynamic therapy for cosmetic applications. Dermatol Ther 2005; 18:242-52.
114. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamjp photorejuvenation. Dermatol Surg 2002;28:742-4; Discussion 744.
115. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA. Splitface comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006;32:795-801; Discussion 801-793.
116. Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of old world cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol 2006;31:634-7.
117. Enk CD, Fritsch C, Jonas F, Nasereddin A, Ingber A, Jaffe CL et al. Treatment of cutaneous leishmaniasis with photodynamic therapy. Arch Dermatol 2003;139:432-4.
118. Gardlo K, Hanneken S, Ruzicka T, Neumann NJ. [Photodynamic therapy of cutaneous leishmaniasis, a promising new therapeutic modality]. Hautarzt 2004;55:381-3.
119. Gardlo K, Horska Z, Enk CD, Rauch L, Megahed M, Ruzicka T et al. Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol 2003; 48:893-6.
120. Stojiljkovic I, Evavold BD, Kumar V Antimicrobial properties of porphyrins. Expert Opin Investig Drugs 2001;10:309-20.